The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.
The global Plasma Fractionation market was valued at US$ 28100 million in 2023 and is anticipated to reach US$ 47210 million by 2030, witnessing a CAGR of 7.6% during the forecast period 2024-2030.
Global Plasma Fractionation key players include Takeda, CSL, Grifols, Octapharma, Kedrion, etc. Global top five manufacturers hold a share about 75%.
North America is the largest market, with a share over 40%, followed by Europe and China, both have a share about 40 percent.
In terms of product, Immune Globulin is the largest segment, with a share about 50%. And in terms of application, the largest application is Immunology, followed by Hematology.
This report aims to provide a comprehensive presentation of the global market for Plasma Fractionation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasma Fractionation.
Report Scope
The Plasma Fractionation market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Plasma Fractionation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plasma Fractionation manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Takeda
- CSL
- Grifols
- Octapharma
- Kedrion
- LFB Group
- Biotest
- BPL
- RAAS
- CBPO
- Hualan Bio
Segment by Type
- Albumin
- Immune Globulin
- Coagulation Factor
- Others
Segment by Application
- Immunology
- Hematology
- Others
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Plasma Fractionation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Plasma Fractionation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Plasma Fractionation Market Overview
1.1 Product Overview and Scope of Plasma Fractionation
1.2 Plasma Fractionation Segment by Type
1.2.1 Global Plasma Fractionation Market Value Comparison by Type (2024-2030)
1.2.2 Albumin
1.2.3 Immune Globulin
1.2.4 Coagulation Factor
1.2.5 Others
1.3 Plasma Fractionation Segment by Application
1.3.1 Global Plasma Fractionation Market Value by Application: (2024-2030)
1.3.2 Immunology
1.3.3 Hematology
1.3.4 Others
1.4 Global Plasma Fractionation Market Size Estimates and Forecasts
1.4.1 Global Plasma Fractionation Revenue 2019-2030
1.4.2 Global Plasma Fractionation Sales 2019-2030
1.4.3 Global Plasma Fractionation Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Plasma Fractionation Market Competition by Manufacturers
2.1 Global Plasma Fractionation Sales Market Share by Manufacturers (2019-2024)
2.2 Global Plasma Fractionation Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Plasma Fractionation Average Price by Manufacturers (2019-2024)
2.4 Global Plasma Fractionation Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Plasma Fractionation, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Plasma Fractionation, Product Type & Application
2.7 Plasma Fractionation Market Competitive Situation and Trends
2.7.1 Plasma Fractionation Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Plasma Fractionation Players Market Share by Revenue
2.7.3 Global Plasma Fractionation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Plasma Fractionation Retrospective Market Scenario by Region
3.1 Global Plasma Fractionation Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Plasma Fractionation Global Plasma Fractionation Sales by Region: 2019-2030
3.2.1 Global Plasma Fractionation Sales by Region: 2019-2024
3.2.2 Global Plasma Fractionation Sales by Region: 2025-2030
3.3 Global Plasma Fractionation Global Plasma Fractionation Revenue by Region: 2019-2030
3.3.1 Global Plasma Fractionation Revenue by Region: 2019-2024
3.3.2 Global Plasma Fractionation Revenue by Region: 2025-2030
3.4 North America Plasma Fractionation Market Facts & Figures by Country
3.4.1 North America Plasma Fractionation Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Plasma Fractionation Sales by Country (2019-2030)
3.4.3 North America Plasma Fractionation Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Plasma Fractionation Market Facts & Figures by Country
3.5.1 Europe Plasma Fractionation Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Plasma Fractionation Sales by Country (2019-2030)
3.5.3 Europe Plasma Fractionation Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Plasma Fractionation Market Facts & Figures by Country
3.6.1 Asia Pacific Plasma Fractionation Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Plasma Fractionation Sales by Country (2019-2030)
3.6.3 Asia Pacific Plasma Fractionation Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Plasma Fractionation Market Facts & Figures by Country
3.7.1 Latin America Plasma Fractionation Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Plasma Fractionation Sales by Country (2019-2030)
3.7.3 Latin America Plasma Fractionation Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Plasma Fractionation Market Facts & Figures by Country
3.8.1 Middle East and Africa Plasma Fractionation Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Plasma Fractionation Sales by Country (2019-2030)
3.8.3 Middle East and Africa Plasma Fractionation Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Plasma Fractionation Sales by Type (2019-2030)
4.1.1 Global Plasma Fractionation Sales by Type (2019-2024)
4.1.2 Global Plasma Fractionation Sales by Type (2025-2030)
4.1.3 Global Plasma Fractionation Sales Market Share by Type (2019-2030)
4.2 Global Plasma Fractionation Revenue by Type (2019-2030)
4.2.1 Global Plasma Fractionation Revenue by Type (2019-2024)
4.2.2 Global Plasma Fractionation Revenue by Type (2025-2030)
4.2.3 Global Plasma Fractionation Revenue Market Share by Type (2019-2030)
4.3 Global Plasma Fractionation Price by Type (2019-2030)
5 Segment by Application
5.1 Global Plasma Fractionation Sales by Application (2019-2030)
5.1.1 Global Plasma Fractionation Sales by Application (2019-2024)
5.1.2 Global Plasma Fractionation Sales by Application (2025-2030)
5.1.3 Global Plasma Fractionation Sales Market Share by Application (2019-2030)
5.2 Global Plasma Fractionation Revenue by Application (2019-2030)
5.2.1 Global Plasma Fractionation Revenue by Application (2019-2024)
5.2.2 Global Plasma Fractionation Revenue by Application (2025-2030)
5.2.3 Global Plasma Fractionation Revenue Market Share by Application (2019-2030)
5.3 Global Plasma Fractionation Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Takeda Plasma Fractionation Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CSL Plasma Fractionation Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 Grifols
6.3.1 Grifols Corporation Information
6.3.2 Grifols Description and Business Overview
6.3.3 Grifols Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Grifols Plasma Fractionation Product Portfolio
6.3.5 Grifols Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Corporation Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Octapharma Plasma Fractionation Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Kedrion
6.5.1 Kedrion Corporation Information
6.5.2 Kedrion Description and Business Overview
6.5.3 Kedrion Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Kedrion Plasma Fractionation Product Portfolio
6.5.5 Kedrion Recent Developments/Updates
6.6 LFB Group
6.6.1 LFB Group Corporation Information
6.6.2 LFB Group Description and Business Overview
6.6.3 LFB Group Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.6.4 LFB Group Plasma Fractionation Product Portfolio
6.6.5 LFB Group Recent Developments/Updates
6.7 Biotest
6.6.1 Biotest Corporation Information
6.6.2 Biotest Description and Business Overview
6.6.3 Biotest Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biotest Plasma Fractionation Product Portfolio
6.7.5 Biotest Recent Developments/Updates
6.8 BPL
6.8.1 BPL Corporation Information
6.8.2 BPL Description and Business Overview
6.8.3 BPL Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.8.4 BPL Plasma Fractionation Product Portfolio
6.8.5 BPL Recent Developments/Updates
6.9 RAAS
6.9.1 RAAS Corporation Information
6.9.2 RAAS Description and Business Overview
6.9.3 RAAS Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.9.4 RAAS Plasma Fractionation Product Portfolio
6.9.5 RAAS Recent Developments/Updates
6.10 CBPO
6.10.1 CBPO Corporation Information
6.10.2 CBPO Description and Business Overview
6.10.3 CBPO Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.10.4 CBPO Plasma Fractionation Product Portfolio
6.10.5 CBPO Recent Developments/Updates
6.11 Hualan Bio
6.11.1 Hualan Bio Corporation Information
6.11.2 Hualan Bio Plasma Fractionation Description and Business Overview
6.11.3 Hualan Bio Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hualan Bio Plasma Fractionation Product Portfolio
6.11.5 Hualan Bio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Plasma Fractionation Industry Chain Analysis
7.2 Plasma Fractionation Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Plasma Fractionation Production Mode & Process
7.4 Plasma Fractionation Sales and Marketing
7.4.1 Plasma Fractionation Sales Channels
7.4.2 Plasma Fractionation Distributors
7.5 Plasma Fractionation Customers
8 Plasma Fractionation Market Dynamics
8.1 Plasma Fractionation Industry Trends
8.2 Plasma Fractionation Market Drivers
8.3 Plasma Fractionation Market Challenges
8.4 Plasma Fractionation Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
